|
|
Join us as theranostics reshapes cancer care.
Let's enter this new era of precision oncology together.
As partners.
|
|
Theranostics is emerging as the fifth pillar of cancer care, combining a diagnostic radioactive drug to "see" the disease with a therapeutic radioactive drug to "treat" it. With the number of theranostics centers in the U.S. expected to triple¹,
the demand for precision oncology tools has never been greater.
At Siemens Healthineers, our molecular imaging systems are designed to provide exceptional precision and evolve with this transformation because building a successful theranostics program starts with confidence: in your technology, your workflows, and your ability to tailor care to each patient.
We offer trusted expertise and a comprehensive value chain to help you achieve exactly that.
|
|
¹ The Journal of Nuclear Medicine. How many theranostics centers will we need in the United States? Available at https://jnm.snmjournals.org/content/jnumed/63/6/805.full.pdf.
|
|
|
|
  |
|
|
| About this email: SmartBrief will occasionally
send emails from our business partners promoting products and services likely to
be of interest to our readers. The content of these messages does not necessarily reflect
the view of SmartBrief or its association partners. |
|
|
|
|
| Copyright © 2025 SmartBrief. All Rights Reserved. A division of Future US LLC. |
| Full 7th Floor, 130 West 42nd Street, New York, NY, 10036. |
|
|
|
